Kathryn Wekselman
Vice President Regulatory @ MaxCyte, Inc.
About Kathryn Wekselman
Kathryn Wekselman serves as the Vice President of Regulatory at MaxCyte, Inc., where she oversees regulatory strategy and submissions. With extensive experience in drug development and regulatory affairs, she has held senior positions at various pharmaceutical companies and has a strong academic background in nursing and librarianship.